Robinson AD et al. revealed that P4HA1 was required for lung cancer cell growth and invasion, suggesting its potential as a valid therapeutic target in lung adenocarcinoma (Robinson et al., 2021). The gene discussed is P4HA1; the disease is lung adenocarcinoma.